Asarfi Hospital
Asarfi Hospital (ASARFI) share price was ₹166.95 at the 28 Oct 2026 close; market capitalisation ₹328 Cr; P/E (TTM) 18.11; sector Healthcare Services. The share price rose 2.0% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 32.8% year on year to ₹47.34 Cr and net profit was ₹4.27 Cr, against ₹3.20 Cr a year earlier (compared with Jun 2025). Promoters held 61.18% of Asarfi Hospital in Sep 2026, up 0.01 percentage points from Jun 2026. Its Tapetide Score is 55/100 (Good) as of 28 Oct 2026.
Key Fundamentals
SMEHealthcare ServicesHealthcarePrice-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM
Peer Comparison
Healthcare › Healthcare Services › Hospitals › Hospital
| ₹8,230.50 | 56.64 | 1,18,342 Cr | 12.48 | 0.26% | 20.08% | 19.79% | 26,675 Cr | 2,171 Cr | |
| ₹638.85 | 85.18 | 84,033 Cr | 5.12 | 0.00% | 10.42% | 9.50% | 11,400 Cr | 906 Cr | |
| ₹860.85 | 57.47 | 83,787 Cr | 7.80 | 0.24% | 13.42% | 12.70% | 8,879 Cr | 1,457 Cr | |
| ₹677.30 | 110.13 | 59,038 Cr | 14.03 | 0.45% | 8.84% | 9.71% | 5,006 Cr | 363 Cr | |
| ₹758.60 | 54.65 | 57,271 Cr | 5.79 | 0.14% | 10.47% | 12.13% | 9,607 Cr | 1,070 Cr | |
| ₹1,301.60 | 62.91 | 34,996 Cr | 8.83 | 0.04% | 13.91% | 15.05% | 4,800 Cr | 552 Cr | |
| ₹1,709.40 | 42.80 | 34,933 Cr | 7.70 | 0.26% | 17.85% | 11.39% | 9,185 Cr | 816 Cr | |
| Asarfi Hospital (this company) | — | 18.11 | 328 Cr | 3.22 | 0.00% | 17.06% | 18.36% | 187 Cr | 18 Cr |
| Median 8 companies | ₹860.85 | 57.06 | 58,155 Cr | 7.75 | 0.19% | 13.67% | 12.42% | 9,032 Cr | 861 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 100/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is expected to give good quarter
- Company has delivered good profit growth of 37.0% CAGR over last 5 years
Weaknesses
1- Though the company is reporting repeated profits, it is not paying out dividend
Technical Indicators
Oscillators
Bullish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 19.9% · Jun 2026
Quarterly Results
| Particulars | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20.05 | 24.04 | 30.86 | 32.89 | 35.1 | 35.66 | 44.85 | 46.06 | 45.03 | 47.34 |
| Expenses | 16.04 | 20.05 | 24.06 | 25.9 | 28.64 | 28.63 | 35.94 | 35.95 | 37.17 | 37.92 |
| Operating Profit | 4.01 | 3.99 | 6.8 | 6.99 | 6.46 | 7.03 | 8.91 | 10.11 | 7.86 | 9.42 |
| OPM % | 20% | 16.6% | 22.03% | 21.25% | 18.4% | 19.71% | 19.87% | 21.95% | 17.46% | 19.9% |
| Other Income | 1.2 | -0.41 | 1.13 | 0.89 | 3.66 | 1.42 | 0.8 | 1.5 | 0.67 | 0.59 |
| Interest | 0.6 | 0.76 | 0.76 | 1.18 | 1.35 | 1.22 | 1.07 | 1.25 | 0.71 | 1.17 |
| Depreciation | 3.25 | 3.49 | 3.18 | 3.04 | 3.23 | 2.96 | 2.88 | 2.86 | 2.74 | 3.13 |
| PBT | 1.36 | -0.67 | 3.99 | 3.66 | 5.54 | 4.27 | 5.76 | 7.5 | 5.08 | 5.71 |
| Tax % | 102.94% | -76.12% | 27.07% | 25.41% | 30.87% | 25.29% | 25.17% | 27.07% | 19.49% | 25.22% |
| Net Profit | -0.05 | -0.16 | 2.9 | 2.72 | 3.83 | 3.2 | 4.3 | 5.48 | 4.09 | 4.27 |
| EPS (₹) | -0.03 | -0.08 | 1.47 | 1.38 | 1.95 | 1.63 | 2.19 | 2.78 | 2.08 | 2.17 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 43 | 54 | 65 | 69 | 81 | 118 | 173 | 183 |
| Expenses | 37 | 46 | 54 | 55 | 65 | 93 | 138 | 147 |
| Operating Profit | 6 | 8 | 11 | 14 | 16 | 25 | 36 | 36 |
| OPM % | 15% | 15% | 17% | 20% | 20% | 21% | 20% | 20% |
| Other Income | 0 | 0 | 1 | 2 | 2 | 6 | 3 | 4 |
| Interest | 1 | 1 | 1 | 1 | 3 | 4 | 4 | 4 |
| Depreciation | 2 | 3 | 3 | 4 | 9 | 13 | 11 | 12 |
| PBT | 4 | 5 | 8 | 11 | 6 | 15 | 23 | 24 |
| Tax % | 27% | 26% | 26% | 26% | 33% | 25% | 24% | — |
| Net Profit | 3 | 4 | 6 | 8 | 4 | 11 | 17 | 18 |
| EPS (₹) | 3.6 | 4.84 | 7.85 | 5.53 | 2.14 | 5.58 | 8.68 | 9.22 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 14 | 20 | 20 | 20 |
| Reserves | 12 | 16 | 21 | 27 | 51 | 62 | 79 |
| Borrowings | 5 | 7 | 12 | 17 | 32 | 49 | 58 |
| Other Liabilities | 9 | 13 | 28 | 34 | 52 | 34 | 38 |
| Total Liabilities | 28 | 37 | 63 | 93 | 154 | 164 | 194 |
| Fixed Assets | 18 | 22 | 31 | 39 | 94 | 101 | 108 |
| CWIP | 0 | 2 | 9 | 18 | 0 | 2 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 9 | 13 | 22 | 37 | 60 | 61 | 84 |
| Total Assets | 28 | 37 | 63 | 93 | 154 | 164 | 194 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 2 | 10 | 9 | 7 | 26 | -4 | 19 |
| Investing | -5 | -16 | -23 | -21 | -63 | -8 | -19 |
| Financing | 2 | 6 | 14 | 15 | 36 | 13 | 5 |
| Net Cash Flow | 0 | 0 | 0 | 1 | -1 | 1 | 5 |
| Free Cash Flow | -5 | 2 | -10 | -13 | -20 | -14 | 1 |
| CFO/EBITDA | 62 | 142 | 104 | 73 | 162 | -3 | 69 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 20 | 14 | 30 | 90 | 109 | 123 | 114 |
| Inventory Days | 23 | 13 | 16 | 26 | 32 | 30 | 30 |
| Days Payable | 156 | 23 | 34 | 91 | 445 | 167 | 156 |
| Cash Conversion Cycle | -113 | 5 | 11 | 25 | -304 | -13 | -12 |
| Working Capital Days | -10 | -38 | -36 | 18 | 3 | 5 | 19 |
| ROCE % | — | 25% | 29% | 26% | 11% | 16% | 19% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Asarfi Hospital insights
62 extracted metrics + investor summaries across FY01–FY27.
Documents
Frequently Asked Questions about Asarfi Hospital
What does Asarfi Hospital Ltd do?
Where is Asarfi Hospital Ltd (ASARFI) listed?
Which sector does Asarfi Hospital Ltd belong to?
What is the market capitalisation of Asarfi Hospital Ltd?
What is the PE ratio of Asarfi Hospital Ltd?
What is the 52-week high and low of Asarfi Hospital Ltd?
What is the Return on Equity (ROE) of Asarfi Hospital Ltd?
Company Information
Incorporated in 2005, Asarfi Hospital Ltd provides primary health services & treatment and specialized super speciality health service[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543943.md for Asarfi Hospital Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.